Aprogen Biologics Inc.
003060.KS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$17.59B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $17.59 Billion |
|---|---|
| Enterprise Value | $206.00 Billion |
| Earnings per Share | $-12923.54 |
| Beta | -0.19 |
| Outstanding Shares | 13,988,000 |
Return
| Return on Equity | -40.31% |
|---|---|
| Return on Assets | -14.28% |
| Return on Invested Capital | -13.80% |
Valuation & Multiples
| P/E Ratio | -0.23 |
|---|---|
| PEG | 0.29 |
| Price to Sales | 0.21 |
| Price to Book Ratio | 0.07 |
| Enterprise Value to Revenue | 2.39 |
| Enterprise Value to EBIT | -4.37 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 1.02 |
| Debt to Equity | 1.09 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Aprogen Biologics Inc.
377 employees
CEO: Jeong-Chool Kim
Aprogen Biologics, Inc. specializes in the production and distribution of pharmaceutical goods. The company's activities are structured across two main segments: Pharmaceutical and Bio. Its Pharmaceutical division supplies synthetic medi...